Company Filing History:
Years Active: 2024
Title: Anli Zhang: Innovator in Cancer Treatment
Introduction
Anli Zhang is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing advanced therapies to improve patient outcomes in oncology.
Latest Patents
Anli Zhang holds a patent for his invention titled "Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy." This patent discloses methods for treating cancers with a telomerase-mediated telomere-targeting drug, 6-thio-2'-deoxyguanosine (6-thio-dG), in combination with checkpoint inhibitors and/or radiation therapy. The methods have shown promise in leading to tumor regression through innate and adaptive immune-dependent mechanisms in syngeneic and humanized mouse cancer models. He has 1 patent to his name.
Career Highlights
Anli Zhang is affiliated with the University of Texas System, where he conducts his research and develops innovative cancer treatment methodologies. His work has garnered attention for its potential to revolutionize cancer therapies and improve patient care.
Collaborations
Anli Zhang collaborates with esteemed colleagues such as Jerry W. Shay and Yang-Xin Fu. Their combined expertise enhances the research efforts and contributes to the advancement of cancer treatment strategies.
Conclusion
Anli Zhang is a dedicated inventor whose work in cancer treatment exemplifies the potential of innovative therapies. His contributions are paving the way for new approaches in oncology, ultimately aiming to improve the lives of patients battling cancer.